| Mrs Tiffany Nicole Parsons, MOT, OTR/L | |
|
387 Heliport Loop, Bridgeport, WV 26330-8604 | |
| (304) 842-0044 | |
| (304) 842-0033 |
| Full Name | Mrs Tiffany Nicole Parsons |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 387 Heliport Loop, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922630649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1727 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tiffany Nicole Parsons, MOT, OTR/L Po Box 1276, Bridgeport, WV 26330-6276 Ph: (304) 842-0044 | Mrs Tiffany Nicole Parsons, MOT, OTR/L 387 Heliport Loop, Bridgeport, WV 26330-8604 Ph: (304) 842-0044 |
News Archive
St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.
Sucampo Pharmaceuticals, Inc. today confirmed that its partner, R-Tech Ueno, Ltd. reported the results of its recently completed phase 2 clinical trial of UF-021 in retinitis pigmentosa patients. The results showed improvement in visual function dose-dependently in both visual field test and subjective findings.
The study, published in the journal Angewandte Chemie International Edition, identified many small molecules that bind to certain parts of the SARS-CoV-2 genome that are less likely altered by mutations using dedicated substance libraries. The scientists derived key functional units and groups in ligands for effective and safe targeting of SARS-CoV-2 RNA.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 8 days ago
Mrs. Jaclyn Michele Belcastro, MS,OT R/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 State St., Best Life Therapy Llc, Bridgeport, WV 26330 Phone: 304-933-3073 Fax: 304-933-3187 | |
Emily Devereux, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 415 Benedum Dr, Bridgeport, WV 26330 Phone: 304-842-9887 | |
Robin Annette Raleigh, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 415 Benedum Dr, Bridgeport, WV 26330 Phone: 304-842-9887 Fax: 304-842-9888 | |
Darian Hope Darway, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1000 S Maplewood Dr, Bridgeport, WV 26330 Phone: 304-933-3338 | |
Madison Elise Bailey, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 387 Heliport Loop, Bridgeport, WV 26330 Phone: 304-842-0044 | |
Danielle Cooper, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Maplewood Dr, Bridgeport, WV 26330 Phone: 304-933-3338 | |
Lyndsey Pittore, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Grande Meadows Dr Ste 102, Bridgeport, WV 26330 Phone: 304-592-2009 Fax: 304-592-2004 |